The impact of coffee on human health

Aleksandra Chałupnik, Aleksandra Borkowska, Anna Sobstyl, Zuzanna Chilimoniuk, Maciej Dobosz, Paulina Sobolewska, Halina Piecewicz-Szczęsna


Introduction: Coffee is one of the most popular beverages in the world. It contains lots of biologically active ingredients. These compounds not only have aromatic properties, but many of them also have antioxidant, hepatoprotective, anti-inflammatory, antimicrobial, antiviral and relaxing smooth muscle properties.
The aim of the study: The purpose of the study is to collect and review scientific publications about the impact of coffee on health.
Material and method: The paper uses standard criteria as the research method. Additionally, during the literature review on PubMed and Google Scholar platforms, keywords such as coffee, caffeine, health, impact were used.
Description of the state of knowledge: Numerous studies suggest that coffee impact on the long-term functioning of the organism is negligible and is associated with the consumption of coffee for a longer period of time. Chlorogenic acid, caffeine and trigoneline are primarily responsible for the positive effect. They have a hypoglycemic, bactericidal and antioxidant effect. Diterpenes, such as kahweol and cafestol may have negative influence on health. Research also suggests that coffee can reduce the risk of Parkinson's disease and type 2 diabetes.
Summary: The results show that coffee ingredients can have both positive and negative effects on health. However, before these observations can be used to create nutritional advice, further research is needed. They will allow a better understanding of the mechanisms of action of the compounds responsible for reduced risk of diabetes mellitus or Parkinson's disease.
Keywords: coffee, caffeine, health, cardiovascular


coffee; caffeine; health; cardiovascular

Full Text:



Bułdak RJ, Hejmo T, Osowski M, Bułdak Ł, Kukla M, Polaniak R, Birkner E. The Impact of Coffee and Its Selected Bioactive Compounds on the Development and Progression of Colorectal Cancer In Vivo and In Vitro. Molecules 2018, 23(12), 3309.

A. Cano-Marquina, J.J. Tarin, A. Cano. The impact of coffee on health. Maturitas 2013, 75(1):7-21.

Farmakopea Polska VIII tom I. Polskie Towarzystwo Farmaceutyczne, Warszawa 2008:1412.

A.Oñatibia-Astibia, R. Franco, E. Martínez-Pinilla. Health benefits of methylxanthines in neurodegenerative diseases, Mol Nutr Food Res. 2017 Jun;61.

Tieges Z, Snel J, Kok A, et al. Caffeine does not modulate inhibitory control. Brain Cogn 2009, 69: 316-327.

Temple JL. Caffeine use in children: What we know, what we have left to learn, and why we should worry. Neurosci and Biobehav Rev 2009, 33: 793-806.

Tanda G, Goldberg SR. Alternation of the Behavioral Effects of Nicotine by Chronic Caffeine Exposure. Pharmacol Biochem Behav 2000, 66(1): 47-64.

I.A. Ludwig, M.N. Clifford, M.E. Lean i wsp., Coffee: biochemistry and potential impact on health. Food Funct. 2014;5(8):1695-717.

Kołodziejczyk-Czepas J, Szejk M, Pawlak A, Żbikowska HM. Właściwości przeciwutleniające kwasu kawowego i jego pochodnych. ŻYWNOŚĆ. Nauka. Technologia. Jakość, 2015, 3 (100), 5-17.

C. Cavin, D. Holzhaeuser, G. Scharf, A. Constable, W. W. Huber and B. Schilter, Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem. Toxicol., 2002, 40, 1155–1163.

R. Urgert and M. B. Katan, The cholesterol-raising factor from coffeebeans, Annu. Rev. Nutr., 1997, 17, 305–324.

Sondermeijer HP, van Marle AG, Kamen P, Krum H. Acute effects of caffeine on heart rate variability. Am J Cardiol. 2002 Oct 15; 90(8):906-7.

Rauh R, Burkert M, Siepmann M, Mueck-Weymann M. Acute effects of caffeine on heart rate variability in habitual caffeine consumers. Clin Physiol Funct Imaging. 2006 May; 26(3):163-6.

Strubelt O, Diederich KW. Experimental treatment of the acute cardiovascular toxicity of caffeine. J Toxicol Clin Toxicol. 1999;37(1):29-33.

Zimmerman PM, Pulliam J, Schwengels J, MacDonald SE. Caffeine intoxication: a near fatality. Ann Emerg Med. 1985 Dec; 14(12):1227-9.

I. Stensvold, A. Tverdal, and B. K. Jacobsen. Cohort study of coffee intake and death from coronary heart disease over 12 years. 1996, BMJ., 312:544–545.

de Vreede-Swagemakers, J.J., Gorgels, A.P., Weijenberg, M.P. et al. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. 1999, J. Clin Epidemiol., 52:601–607.

Nurminen, M.L., Niittynen, L., Korpela, R., and Vapaatalo, H. Coffee, caffeine and blood pressure: a critical review. 1999, Eur. J. Clin. Nutr., 53:831–839.

Espíndola KMM, Ferreira RG, Narvaez LEM, Silva Rosario ACR, da Silva AHM, Silva AGB, Vieira APO, Monteiro MC. Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma, Front Oncol. 2019; 9: 541.

Song Y, Wang Z, Jin Y, Guo J. Association between tea and coffee consumption and brain cancer risk: an updated meta-analysis. World J Surg Oncol. 2019; 17: 51.

Zhang J, Zhou B, Hao C. Coffee consumption and risk of esophageal cancer incidence. 2018 Apr; 97(17): e0514.

Miranda J, Monteiro L, Albuquerque R, Pacheco JJ. Coffee is protective against oral and pharyngeal cancer: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2017 Sep; 22(5): e554–e561.

Narita S, Saito E, Sawada N, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Noda M, Inoue M, Tsugane S. Coffee Consumption and Lung Cancer Risk: The Japan Public Health Center-Based Prospective Study. J Epidemiol. 2018; 28(4): 207–213.

Lafranconi A, Micek A, Galvano F, Rossetti S, Del Pup L, Berretta M, Facchini G. Coffee Decreases the Risk of Endometrial Cancer: A Dose–Response Meta-Analysis of Prospective Cohort Studies. Nutrients. 2017 Nov; 9(11): 1223.

Lloyd T, Rollings NJ., Kieselhorst K, et al. Dietary caffeine intake is not correlated with adolescent bone gain. 1998, J. Am. Coll Nutr.,17:454–457

Rapuri PB, Gallagher JC, Kinyamu HK., and Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. 2001, Am. J. Clin. Nutr., 74:694–700.

Harris SS and Dawson-Hughes B. Caffeine and bone loss in healthy postmenopausal women. 1994, Am. J. Clin. Nutr., 60:573–578.

Navarro AM, Abasheva D, Martínez-González MA, Ruiz-Estigarribia L, Martín-Calvo N, Sánchez-Villegas A and Toledo E. Coffee Consumption and the Risk of Depression in a Middle-Aged Cohort: The SUN Project. Nutrients. 2018 Sep; 10(9): 1333.

Godos J, Pluchinotta FR, Marventano S, Buscemi S, Volti GL, Galvano F, Grosso G. Coffee components and cardiovascular risk: Beneficial and detrimental effects. Int. J. Food Sci. Nutr. 2014;65:925–936.

Sanchez-Villegas A., Martinez-González M.A. Diet, a new target to prevent depression? BMC Med. 2013;11:3.

Adan A, Prat G, Fabbri M, Sanchez-Turet M. Early effects of caffeinated and decaffeinated coffee on subjective state and gender differences. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2008;32:1698–1703.

Evans AH, Lawrence AD, Potts J, MacGregor L, Katzenschlager R, Shaw K, Zijlmans J, Lees AJ. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):317-21.

Ascherio A, Weisskopf MG, O'Reilly EJ, McCullough ML, Calle EE, Rodriguez C, Thun MJ. Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol. 2004 Nov 15; 160(10):977-84.

Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000 May 24-31; 283(20):2674-9.

Qi H, Li S. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatra Gerontol Int. 2014 Apr; 14(2):430-9.

Ascherio A, Chen, H., Schwarzschild, M.A. et al. Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease. Neurology. 2003, 60:790–795.

Pollock BG, Wylie M, Stack JA. et al. Inhibition of caffeinene metabolism by estrogen replacement therapy in postmenopausal women. J. Clin. Pharmacol. 1999, 39:936–940.

Popat RA, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, McGuire V, Costello S, Manthripragada AD, Southwick A, Myers RM, Nelson LM. Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol. 2011 May; 18(5):756-65.

Schwarzschild MA. Caffeine in Parkinson disease: better for cruise control than snooze patrol? Neurology. 2012 Aug 14; 79(7):616-8.

Bara-Jimenez W, Sherzai A, Dimitrova T, Favit A, Bibbiani F, Gillespie M, Morris MJ, Mouradian MM, Chase TN. Adenosine A(2A) receptor antagonist treatment of Parkinson's disease. Neurology. 2003 Aug 12; 61(3):293-6.

Chen X, Lan X, Roche I, Liu R, Geiger JD. Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem. 2008 Nov; 107(4):1147-57.

Sääksjärvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Männistö S. Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr. 2008 Jul; 62(7):908-15.

Derkinderen P, Shannon KM, Brundin P. Gut feelings about smoking and coffee in Parkinson's Disease. Mov Disord. 2014 Jul; 29(8): 976–979.

Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease. PLoS One. 2011;6(12):e28032.

Chen LW, Wu Y, Neelakantan N, Chong MF, Pan A, van Dam RM. Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose–response meta-analysis of prospective studies. Public Health Nutr. 2016 May;19(7):1233-44.

Bracken MB, Triche E, Grosso L et al. Heterogeneity in assessing self-reports of caffeine exposure: Implications for studies of health effects. Epidemiology. 2002, 13:165–171.

Leviton A, and Cowan L. A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food Chem Toxicol. 2002, 40:1271–1310.

Grosso LM, Bracken MB. Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol. 2005;15(6):460–6.

Ebrahimi A, Habibi-Khorassani M, Akher FB, Farrokhzadeh A, Karimi P. Caffeine as base analogue of adenine or guanine: a theoretical study. J Mol Graph Model 2013;42:81–91.

Martin TR and Bracken MB. The association between low birth weight and caffeine consumption during pregnancy. Am. J. Epidemiol. 1987,126:813–821.

McDonald AD, Armstrong BG and Sloan M.. Cigarette, alcohol, and coffee consumption and prematurity. Am. J. Public Health. 1992, 82:87–90.

Grimm VE, Frieder B. Prenatal caffeine causes long lasting behavioral and neurochemical changes. Int J Neurosci . 1988;41(1-2):15–28.

Rivkees SA, Zhao Z, Porter G, Turner C. Influences of adenosine on the fetus and newborn. Mol Genet Metab 2001; 74: 160–171.

Santos IS, Matijasevich A, Domingues MR. Maternal caffeine consumption and infant nighttime waking: prospective cohort study. Pediatrics. 2012;1295:860–868.

Bekkhus M, Skjøthaug T, Nordhagen Ret al. Intrauterine exposure to caffeine and inattention/overactivity in children. Acta Paediatr . 2010;996:925–928.

Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefield PG, Ryan KJ. No Association between Coffee Consumption and Adverse Outcomes of Pregnancy. N Engl J Med 1982; 306:141-145.

Keijzers GB, De Galan BE, Tack CJ, Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care. 2002 Feb;25(2):364-9.

Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 1998;56:317–333.

Arion WJ, Canfield WK, Ramos FC et al. Chlorogenic acid and hydroxynitrobenzaldehyde: New inhibitors of hepatic glucose 6-phosphatase. Arch. Biochem Biophys. 1997, 339:315–322.

Welsch CA, Lachance PA and Wasserman BP. Dietary phenolic compounds: Inhibition of Na+-dependent D-glucose uptake in rat intestinal brush border membrane vesicles. J. Nutr. 1989, 119:1698–1704.

van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002;360:1477–1478.

Tuomilehto J, Hu G and Bidel S. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA. 2004, 291:1213–1219.



  • There are currently no refbacks.

Copyright (c) 2019 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

POL-index 2011 - 2014

BASE 2011 - 2014

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

Find a library that holds this journal:

Journal Language(s): English 

PBN Poland



Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2 Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase


Universal Impact Factor 1.78 for year 2012. (

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ)

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski